Tags PFAS Disposal
Tag: PFAS Disposal
BioLargo’s AEC PFAS platform continues to prove promising, but underreported risks in operational resilience might complicate further commercialization.
BioLargo expands PFAS, Clyra, and BLEST operations while working to recover from the financial fallout tied to Pooph®.
BioLargo enters early commercialization with Clyra and PFAS, but steep revenue loss from Pooph® collapse leaves execution and scaling critical in 2026.
BioLargo's Q3 2025 report shows tech traction in PFAS, Clyra™, and Cellinity™ — but monetization remains elusive post-Pooph® fallout.
BioLargo's Q2 exposes value-chain gaps—regulatory lags, partner dependency, and no clear path from validation to revenue.
BioLargo’s growth hinges on its AEC, Clyra™, and Pooph® innovations, but delays and cash burn turn Q2–Q3 into a critical test for its long-term ambitions.
BioLargo CEO Dennis P. Calvert appointed to the U.S. Environmental Technologies Trade Advisory Committee as company celebrates 80% revenue growth in 2024.
BioLargo, Inc. starts its Lake Stockholm PFAS removal pilot this month with its efficient AEC technology, reducing hazardous waste by over 99% compared to GAC.
